Literature DB >> 29453165

Endoscopic submucosal dissection for the diagnosis and therapy of pedunculated gastric cancer with prolapse into the duodenal bulb: A case report.

Norihiko Suzuki1, Masashi Yoshida2, Hironori Ohdaira1, Tomonori Imakita1, Nobuhiro Tsutsui1, Yasunobu Kobayashi1, Junji Takahashi1, Shinya Okada3, Masaki Kitajima1, Yutaka Suzuki1.   

Abstract

INTRODUCTION: Preoperative diagnosis of gastric cancer invasion is not always sufficiently accurate. Diagnostic endoscopic submucosal dissection (ESD) can be performed for the purpose of accurate decision making and to avoid partial treatment vs aggressive over-treatment. We present a patient with the gastric cancer with indeterminate pre-operative diagnosis for depth of the invasion. CASE
PRESENTATION: A 70-year-old man presented at our hospital because both anti-Helicobacter pylori (Hp) IGG antibody and serum pepsinogen (PG) levels were classified as positive. Upper gastrointestinal endoscopy was performed, and a large (3.5 cm) pedunculated polyp-shaped gastric cancer with prolapse into the duodenal bulb was found. [fluorine-18]-fluorodeoxy-glucose (18F-FDG)-positron emission tomography (PET)/computed tomography (CT) imaging showed high 18F-FDG uptake, suggesting the possibility of advanced gastric cancer. Since the pre-operative diagnosis of the cancer invasion was indeterminable, diagnostic ESD was performed. The pathohistological diagnosis was early gastric cancer (33 × 35 × 20 mm, well differentiated tubular adenocarcinoma [tub1], pT1a[M], ly[--], v[--], UL[--], pHM0, pVM0) according to the Japanese classification of gastric carcinoma. DISCUSSION AND
CONCLUSION: It was reported that ESD for early gastric cancers that met the expanded criteria was acceptable and should be the standard treatment instead of gastrectomy. The expanded criteria included cancer confined to the mucosa (cT1a), a single primary intestinal-type gastric adenocarcinoma, an ulcer-negative lesion of any size. We reported a case of pedunculated gastric cancer with prolapse into the duodenal bulb that could be treated by ESD. The present case is a good example of diagnostic ESD being used to minimize the damage of gastric cancer treatment.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Diagnostic endoscopic submucosal dissection; Pedunculated polyp-shaped gastric cancer; Preoperative diagnosis; Prolapse into the duodenal bulb

Year:  2018        PMID: 29453165      PMCID: PMC5849812          DOI: 10.1016/j.ijscr.2018.02.004

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Preoperative diagnosis of gastric cancer invasion is not always sufficiently accurate: pre- and post-ESD discrepancies were reported to be 20.1% [1]. Using high-frequency ultrasound probe sonography, it was found that the depth of early gastric cancer was also not accurately determined in 10% of cases [2]. Diagnostic endoscopic submucosal dissection (ESD) can be performed for the purpose of minimizing the treatment or avoiding over-treatment. We encountered a patient with large (3.5 cm) pedunculated polyp-shaped gastric cancer with prolapse into the duodenal bulb. In order to determine the depth of invasion, diagnostic ESD was performed. This paper has been reported in line with the SCARE criteria [3].

Case presentation

A 70-year-old man underwent gastric cancer screening by combined assay for serum anti-Helicobacter pylori (Hp) IGG antibody and serum pepsinogen (PG) levels [4]. He presented at our institute because both anti-Hp IGG antibody and PG were classified as positive: individuals with PG I levels of ≤70 μg/l and a PG I/II ratio of < 3 were classified as PG-positive, and those with a serum Hp antibody titer of > 10 U/ml were classified as anti-Hp IGG antibody positive. Upper gastrointestinal endoscopy was performed, and a large (3.5 cm) pedunculated polyp with prolapse into the duodenal bulb was found (Fig. 1). The prolapse was easily corrected, and it was located at the anterior wall of the antrum. At biopsy, the tumor was histologically diagnosed as a well differentiated tubular adenocarcinoma.
Fig. 1

Endoscopic Findings.

1A: A large pedunculated polyp with prolapse into the duodenal bulb was found.

1B: The prolapse was easily corrected.

1C: The tumor size was about 3.5 cm.

Endoscopic Findings. 1A: A large pedunculated polyp with prolapse into the duodenal bulb was found. 1B: The prolapse was easily corrected. 1C: The tumor size was about 3.5 cm. Abdominopelvic computed tomography (CT) showed the pedunculated polyp with prolapse into the duodenal bulb without evidence of distant metastasis or lymph node metastasis (Fig. 2). [fluorine-18]-fluorodeoxy-glucose (18F-FDG)-positron emission tomography (PET)/computed tomography (CT) imaging showed high 18F-FDG uptake, suggesting the possibility of advanced gastric cancer (Fig. 3). Since the pre-operative diagnosis of the cancer invasion was indeterminable, diagnostic ESD was performed. A dual knife (Electrosurgical Knife [KD-650L]; Olympus) was used for marking, mucosal incision, and submucosal dissection, and hyaluronic-acid containing solution was used as a submucosal fluid cushion. ESD was completed without complications, and the tumor was resected in an en bloc fashion (Fig. 4). The post-ESD course was uneventful. The pathohistological diagnosis was early gastric cancer (33 × 35 × 20 mm, well differentiated tubular adenocarcinoma [tub1], pT1a[M], ly[--], v[--], UL[--], pHM0, pVM0 [Fig. 5]) according to the Japanese classification of gastric carcinoma [5].
Fig. 2

Findings of contrast-enhanced computed tomography.

Abdominopelvic computed tomography (CT) showed the pedunculated polyp with prolapse into the duodenal bulb with no evidence of distant metastasis or lymph node metastasis.

Fig. 3

[fluorine-18]-fluorodeoxy-glucose (18F-FDG)-positron emission tomography (PET)/computed tomography (CT).

18F-FDG- PET/CT imaging showed high 18F-FDG uptake, suggesting the possibility of advanced gastric cancer.

Fig. 4

ESD.

A dual knife (Electrosurgical Knife [KD-650L]; Olympus) was used for marking, mucosal incision, and submucosal dissection, and hyaluronic-acid containing solution was used as a submucosal fluid cushion. The tumor was resected in an en bloc fashion.

Fig. 5

Pathohistological findings.

Adenocarcinoma, tub1, pT1a(M), ly(−), v(−), UL(−), 33 × 35 × 20 mm in size

A) A cut section of the polypoid lesion (HE stain, loupe image),

B) Atypical foveolar epithelium in the top of the polyp (HE stain, object lens×20),

C) Fusiogenic atypical glands in the bottom of the polyp (HE stain, object lens ×20),

D) No stalk invasion, stump free, pHM0, pVM0. (HE stain, object lens ×2),

E) Immunohistochemical stain of Desmin, no invasion to muscularis mucosae of the stalk (object lens ×2).

Findings of contrast-enhanced computed tomography. Abdominopelvic computed tomography (CT) showed the pedunculated polyp with prolapse into the duodenal bulb with no evidence of distant metastasis or lymph node metastasis. [fluorine-18]-fluorodeoxy-glucose (18F-FDG)-positron emission tomography (PET)/computed tomography (CT). 18F-FDG- PET/CT imaging showed high 18F-FDG uptake, suggesting the possibility of advanced gastric cancer. ESD. A dual knife (Electrosurgical Knife [KD-650L]; Olympus) was used for marking, mucosal incision, and submucosal dissection, and hyaluronic-acid containing solution was used as a submucosal fluid cushion. The tumor was resected in an en bloc fashion. Pathohistological findings. Adenocarcinoma, tub1, pT1a(M), ly(−), v(−), UL(−), 33 × 35 × 20 mm in size A) A cut section of the polypoid lesion (HE stain, loupe image), B) Atypical foveolar epithelium in the top of the polyp (HE stain, object lens×20), C) Fusiogenic atypical glands in the bottom of the polyp (HE stain, object lens ×20), D) No stalk invasion, stump free, pHM0, pVM0. (HE stain, object lens ×2), E) Immunohistochemical stain of Desmin, no invasion to muscularis mucosae of the stalk (object lens ×2). After the patient discharged from our hospital, upper gastrointestinal endoscopy (9 month after the ESD: Fig. 6) and abdominopelvic CT (12 month after the ESD) was performed and revealed no recurrence. The latest visit to our hospital was 14 month after the ESD and no sign of recurrence was observed.
Fig. 6

Upper gastrointestinal endoscopy performed 9 month after the ESD.

No local recurrence was found by the upper gastrointestinal endoscopy performed 9 month after the ESD.

Upper gastrointestinal endoscopy performed 9 month after the ESD. No local recurrence was found by the upper gastrointestinal endoscopy performed 9 month after the ESD.

Discussion

The present case is a good example of diagnostic ESD possibly minimizing the damage of gastric cancer treatment. It was reported that ESD for early gastric cancers that met the expanded criteria [6] for intestinal-type gastric cancer (cT1a) was acceptable and should be the standard treatment instead of gastrectomy [7]. The expanded criteria included cancer confined to the mucosa (cT1a), a single primary intestinal-type gastric adenocarcinoma, an ulcer-negative lesion of any size, or a ≤3 cm ulcer-positive lesion, cN0M0, and no prior treatment. Preoperative diagnosis of the depth of cancer invasion in the present case was uncertain because the size, especially the height of the tumor, was large. However, it was speculated that the cancer invasion was, at most, confined to the submucosa because the cancer had a pedunculated shape. Therefore, diagnostic ESD was performed. Pathohistological diagnosis revealed that the resection was curative and met the expanded criteria, so gastrectomy was not required. We reported a case of pedunculated gastric cancer with prolapse into the duodenal bulb that could be treated by ESD. The present case is a good example of diagnostic ESD being used to minimize the damage of gastric cancer treatment.

Conflict of interest

The authors declare no conflict of interests related to this article.

Funding

None.

Ethical approval

Written informed consent was obtained from the patient for publication of these case reports and accompanying images. This is a report of a case and written informed consent was obtained from the patients for publication of these case reports and accompanying images. The ethical approval of this case report was exempted by International University of Health and Welfare Hospital.

Consent

This patient was properly informed and gave consent for his clinical information to be included in an Elsevier publication.

Author contribution

Norihiko Suzuki and Masashi Yoshida performed the procedure, wrote the manuscript and is responsible for the information. Norihiko Suzuki, Yasunobu Kobayashi, Junji Takahashi, Nobuhiro Tsutsui and Tomonori Imakita assisted the procedure and were in charge of the post ESD management. Phathohistological diagnosis was provided by Shinya Okada. Hironori Ohdaira, Masaki Kitajima and Yutaka Suzuki critically reviewed and assisted to write the manuscript..

Guarantor

Masashi Yoshida is the guarantor of this paper.
  7 in total

1.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

2.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

Review 3.  Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.

Authors:  Yasuharu Yamaguchi; Yasuhiko Nagata; Ryuuta Hiratsuka; Yoshihiko Kawase; Tatsurou Tominaga; Shunji Takeuchi; Shinya Sakagami; Shusei Ishida
Journal:  Digestion       Date:  2016-01-14       Impact factor: 3.216

4.  Diagnostic ability of high-frequency ultrasound probe sonography in staging early gastric cancer, especially for submucosal invasion.

Authors:  S Yoshida; S Tanaka; K Kunihiro; Y Mitsuoka; M Hara; Y Kitadai; J Hata; M Yoshihara; K Haruma; N Hayakawa; K Chayama
Journal:  Abdom Imaging       Date:  2005 Sep-Oct

5.  A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607).

Authors:  Noriaki Hasuike; Hiroyuki Ono; Narikazu Boku; Junki Mizusawa; Kohei Takizawa; Haruhiko Fukuda; Ichiro Oda; Hisashi Doyama; Kazuhiro Kaneko; Shinichiro Hori; Hiroyasu Iishi; Yukinori Kurokawa; Manabu Muto
Journal:  Gastric Cancer       Date:  2017-02-21       Impact factor: 7.370

6.  The SCARE Statement: Consensus-based surgical case report guidelines.

Authors:  Riaz A Agha; Alexander J Fowler; Alexandra Saeta; Ishani Barai; Shivanchan Rajmohan; Dennis P Orgill
Journal:  Int J Surg       Date:  2016-09-07       Impact factor: 6.071

7.  Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep).

Authors:  Joon Mee Kim; Jin Hee Sohn; Mee-Yon Cho; Woo Ho Kim; Hee Kyung Chang; Eun Sun Jung; Myeong-Cherl Kook; So-Young Jin; Yang Seok Chae; Young Soo Park; Mi Seon Kang; Hyunki Kim; Jae Hyuk Lee; Do Youn Park; Kyoung Mee Kim; Hoguen Kim; Youn Wha Kim; Seung-Sik Hwang; Sang Yong Seol; Hwoon-Yong Jung; Na Rae Lee; Seung-Hee Park; Ji Hye You
Journal:  Gastric Cancer       Date:  2015-11-30       Impact factor: 7.370

  7 in total
  2 in total

1.  Benign Blockage: Gastric Outlet Obstruction due to a Prolapsing Gastric Pedunculated Polyp-Case Report and Literature Review.

Authors:  N Zorzetti; A Lauro; V D'Andrea; A Ruffato; L Ferruzzi; N Antonacci; R M Tranchino
Journal:  Dig Dis Sci       Date:  2021-02-26       Impact factor: 3.199

2.  Spatiotemporal multi-scale modeling of radiopharmaceutical distributions in vascularized solid tumors.

Authors:  Mohammad Kiani Shahvandi; M Soltani; Farshad Moradi Kashkooli; Babak Saboury; Arman Rahmim
Journal:  Sci Rep       Date:  2022-08-26       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.